(Press-News.org) Boston, MA and Rolle, Switzerland, September 14, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at the European Society for Medical Oncology (ESMO) 2024. The study, conducted in collaboration with AstraZeneca, leverages advanced AI-driven techniques to identify subgroups of stage IV non-small cell lung cancer (NSCLC) patients who could most benefit from the addition of tremelimumab to durvalumab and chemotherapy.
The research is a retrospective, multimodal analysis of the POSEIDON Phase 3 clinical trial (NCT03164616). This trial originally demonstrated that the combination of tremelimumab, durvalumab, and chemotherapy significantly increases progression-free survival (PFS) and overall survival (OS) versus chemotherapy in patients with metastatic NSCLC, which lead to approval of this regiment globally in 1L mNSCLC. The SOPHiA GENETICS study used cutting-edge multimodal machine learning models to analyze clinical, biological, genomic, and imaging data, pinpointing patient subgroups who are most likely to benefit from the combination treatment.
The research highlighted signatures identifying patients with non-squamous metastatic NSCLC who may derive higher OS benefit from the addition of tremelimumab to durvalumab plus chemotherapy in the first-line treatment setting. In particular, EGFR wild-type, FGFR3 wild-type, CDKN2A wild-type, KRAS mutation, and STK11 mutation comprised elements of a signature was identified as being associated with a higher OS benefit. These findings could have significant implications for the treatment of NSCLC, as it provides an exploration avenue towards a more tailored approach to patient care.
"Our collaboration with AstraZeneca represents a major step forward in personalized oncology. Non-small cell lung cancer remains one of the most challenging cancers to treat due to its complex biology and the late stage at which it is often diagnosed,” said Jurgi Camblong, Ph.D., Co-founder and CEO of SOPHiA GENETICS. “This study harnesses the power of multimodal data and advanced AI to identify which patients are most likely to benefit from specific therapies. By tailoring treatment strategies based on a patient's unique multimodal profile, we aim to improve outcomes and offer new hope to those battling this difficult disease."
The study will be presented as a poster by Ferdinandos Skoulidis, Department of Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center at ESMO 2024 hosted in Barcelona, Spain from September 13-17, 2024. His presentation showcases the operational feasibility and clinical impact of large-scale multimodal analyses in identifying heterogeneous treatment effects in oncology.
For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn.
# # #
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
SOPHiA GENETICS Forward-Looking Statements:
This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.
Media Contact:
Kelly Katapodis
media@sophiagenetics.com
END
Bile acids are essential signaling molecules derived from cholesterol metabolism in the liver and are crucial for the digestion and absorption of fats. These molecules undergo further modification in the intestines by the gut microbiome. However, disruptions in bile flow, a condition known as cholestasis, can lead to the pathological accumulation of hydrophobic BAs in the liver and bloodstream. This accumulation not only exacerbates liver damage but also induces significant disturbances in cellular processes. The review focuses on recent developments in understanding how BAs contribute to liver injury by affecting mitochondrial function, endoplasmic reticulum ...
Tokyo, Japan – Researchers from Tokyo Metropolitan University have made strides forward in realizing industrial conversion of bicarbonate solution made from captured carbon to a formate solution, a green fuel. Their new electrochemical cell, with a porous membrane layer in between the electrodes, overcomes major issues suffered in reactive carbon capture (RCC) and achieves performances rivaling energy-hungry gas-fed methods. Processes like theirs directly add value to waste streams and are key to realizing net zero emissions.
Carbon capture technology ...
Lakes can tip the scales from healthy to potential environmental hazard quickly when they become eutrophic. In this state, an abundance of nutrients accelerates algae growth, which then crowd the water’s surface and block light from reaching organisms below. Without light, they can’t make oxygen and life in the water begins to die off. Luckily, researchers can monitor inland lakes for eutrophication with remote sensing technologies; however, those technologies could be adjusted to make more accurate assessments, according to researchers based in China.
The team published their evaluation of the technologies, as well as recommended paths ...
While planting trees may seem like an easy win to combat climate change, planted forests often encroach on natural forests, wetlands, and grasslands. This can reduce biodiversity, disturb the natural environment, and disrupt carbon and water cycling. While there has been a global increase in forest cover, it’s hard to know if this forest is the regeneration and growth of natural forests or if it is planting new trees. Accurately mapping these forests with remote sensing technology could help.
However, comprehensive maps of planted forests and natural forests are lacking even though it is possible to distinguish planted forests and natural forests on satellite images ...
CHICAGO—September 13, 2024—The College of Architecture at Illinois Institute of Technology has been awarded the prestigious Zero Energy Design Designation (ZEDD) from the United States Department of Energy (DOE) for it Bachelor of Architecture and Master of Architecture programs. This recognition highlights the college’s commitment to sustainability, carbon neutrality, and zero-energy design practices in a world of escalating extreme weather and climate change.
The ...
HOUSTON – (Sept. 13, 2024) – Generative artificial intelligence (AI) has notoriously struggled to create consistent images, often getting details like fingers and facial symmetry wrong. Moreover, these models can completely fail when prompted to generate images at different image sizes and resolutions.
Rice University computer scientists’ new method of generating images with pre-trained diffusion models ⎯ a class of generative AI models that “learn” by adding layer after layer of random noise to the images they are trained on and then generate new images by removing the added noise ⎯ could help correct ...
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises—both in the United States and around the world. NIH’s National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately ...
University of Virginia professor Mathews Jacob has secured a $3.9 million grant to advance his innovative research on detecting Alzheimer’s disease in its early stages. Jacob, who specializes in electrical and computer engineering, is teaming up with researchers from the University of Iowa and the University of California-San Francisco to push the boundaries of imaging technology that tracks the brain’s metabolic changes — offering a fresh perspective on studying neurodegenerative disorders.
Their focus is on advancing magnetic resonance spectroscopic imaging (MRSI). Unlike standard MRI, which primarily highlights structural changes, ...
Flowers like hibiscus use an invisible blueprint established very early in petal formation that dictates the size of their bullseyes – a crucial pre-pattern that can significantly impact their ability to attract pollinating bees.
The study, by researchers at the University of Cambridge’s Sainsbury Laboratory also found that bees prefer larger bullseyes over smaller ones and fly 25% faster between artificial flower discs with larger bullseyes – potentially boosting efficiency for both bees and blossoms.
Patterns on the flowers of plants guide insects, like bees, to the centre of the flower, where nectar and pollen await, ...
Men are three times more likely than women to commit traffic violations while driving and to be involved in accidents. Moreover, they are more likely to create situations on the road that are highly dangerous to others. Men are also twice as likely to drive under the influence and nearly one-third more likely to receive a prison sentence for reckless driving. Perhaps it comes down to cultural norms and the different attitudes men and women have toward driving. These are the conclusions reached by Anton Kazun, Assistant Professor at the HSE Faculty of Economic Sciences, and Research Assistant Mikhail Belov.
There is a stereotype that women are worse driver than men; female drivers are ...
